# Implantation awakens peri-implant osteogenic potential via Snx5-EGFR axis-mediated mechanical transduction

**Authors:** Xue Jiang, Yuteng Weng, Yanhuizhi Feng, Jie Huang, Haicheng Wang, Zuolin Wang

PMC · DOI: 10.1038/s41368-025-00423-2 · International Journal of Oral Science · 2026-02-20

## TL;DR

This study reveals that Snx5 helps convert mechanical signals into bone growth, and its absence impairs healing around dental implants.

## Contribution

The study identifies Snx5 as a novel regulator of mechanosensitive bone remodeling via EGFR signaling.

## Key findings

- Snx5 deficiency disrupts mechanosensitive activation of LepR+ MSCs and reduces implant-induced osteogenesis.
- Snx5 facilitates p-EGFR recycling to sustain EGFR signaling, and its loss redirects EGFR toward degradation.
- Snx5 plays a previously unrecognized role in peri-implant bone adaptation in response to mechanical cues.

## Abstract

Alveolar bone resorption during the socket healing process compromises subsequent restoration outcomes. Recent clinical evidence suggests that dental implant placement can effectively prevent such bone loss, yet the mechanisms remain elusive. In this study, combined multi-dataset screening pinpointed sorting nexin 5 (Snx5) as a potential regulator of mechanotransduction, whose expression was downregulated in early peri-implant bone remodeling zones following implant placement. Functional studies showed that loss of Snx5 abolished the additional osteogenic enhancement normally induced by mechanical stimulation. In vivo, Snx5 deficiency disrupted the mechanosensitive activation of LepR+ MSCs and compromised implant-induced osteogenesis. Mechanistically, Snx5 facilitates the recycling of phosphorylated EGFR (p-EGFR) back to the plasma membrane to sustain EGFR signaling. Loss of Snx5 redirects EGFR trafficking toward late endosomes and lysosomal degradation, thereby weakening its signaling. These findings uncover a previously unrecognized role for Snx5 in mediating the osteogenic fate of peri-implant BMSCs in response to mechanical cues, expanding the functional repertoire of the Snx family. Collectively, these findings highlight Snx5 as a novel regulator of mechanosensitive bone remodeling and suggest that its downregulation may contribute to peri-implant bone adaptation. This study provides new insights into how the mechanical microenvironment regulates bone repair and highlights Snx5 as a promising molecular target for modulating skeletal mechano-responsiveness in clinical bone regeneration.

## Linked entities

- **Genes:** SNX5 (sorting nexin 5) [NCBI Gene 27131], EGFR (epidermal growth factor receptor) [NCBI Gene 1956], LEPR (leptin receptor) [NCBI Gene 3953]
- **Proteins:** EGFR (epidermal growth factor receptor)

## Full-text entities

- **Genes:** Piezo1 (piezo-type mechanosensitive ion channel component 1) [NCBI Gene 234839] {aka 9630020g22, Fam38a, mKIAA0233}, Col1a1 (collagen, type I, alpha 1) [NCBI Gene 12842] {aka Col1a-1, Cola-1, Cola1, Mov-13, Mov13}, Yap1 (yes-associated protein 1) [NCBI Gene 22601] {aka Yap, Yap65, Yki, Yorkie}, Pcna (proliferating cell nuclear antigen) [NCBI Gene 18538], EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Lepr (leptin receptor) [NCBI Gene 16847] {aka B219, LEP-R, LEPROT, Leprb, Modb1, OB-RGRP}, SNX5 (sorting nexin 5) [NCBI Gene 27131], Lamp1 (lysosomal-associated membrane protein 1) [NCBI Gene 16783] {aka CD107a, LGP-120, LGP-A, Lamp-1, P2B, Perk}, Runx2 (runt related transcription factor 2) [NCBI Gene 12393] {aka AML3, CBF-alpha-1, Cbf, Cbfa-1, Cbfa1, LS3}, Snx5 (sorting nexin 5) [NCBI Gene 69178] {aka 0910001N05Rik, 1810032P22Rik, D2Ertd52e}, Nanog (Nanog homeobox) [NCBI Gene 71950] {aka 2410002E02Rik, ENK, Stm1, ecat4}, Jun (Jun proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 16476] {aka AP-1, Junc, c-jun}, Sox2 (SRY (sex determining region Y)-box 2) [NCBI Gene 20674] {aka Sox-2, lcc, ysb}, Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, Alpl (alkaline phosphatase, liver/bone/kidney) [NCBI Gene 11647] {aka ALP, APTNAP, Akp-2, Akp2, TNAP, TNSALP}, Top2a (topoisomerase (DNA) II alpha) [NCBI Gene 21973] {aka Top-2}, Slurp1 (secreted Ly6/Plaur domain containing 1) [NCBI Gene 57277] {aka 1110021N19Rik, ARS, ArsB, Slurp-1}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, LEPR (leptin receptor) [NCBI Gene 3953] {aka CD295, LEP-R, LEPRD, OB-R, OBR, huB219}, alp (alopecia, recessive) [NCBI Gene 11691], Egfr (epidermal growth factor receptor) [NCBI Gene 13649] {aka 9030024J15Rik, Erbb, Errb1, Errp, Wa5, wa-2}, Ephb2 (Eph receptor B2) [NCBI Gene 13844] {aka Cek5, Drt, ETECK, Erk, Hek5, Nuk}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Piezo2 (piezo-type mechanosensitive ion channel component 2) [NCBI Gene 667742] {aka 5930434P17, 9030411M15Rik, 9430028L06Rik, Fam38b, Fam38b2}, Eea1 (early endosome antigen 1) [NCBI Gene 216238] {aka A430109M19Rik, B230358H09Rik, ZFYVE2}, Col3a1 (collagen, type III, alpha 1) [NCBI Gene 12825] {aka Col3a-1, Tsk-2, Tsk2}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, Prrx1 (paired related homeobox 1) [NCBI Gene 18933] {aka A230024N07Rik, K-2, MHox1, Pmx, Pmx1, Prx1}, Rab7 (RAB7, member RAS oncogene family) [NCBI Gene 19349] {aka Rab7a}, Sp7 (Sp7 transcription factor 7) [NCBI Gene 170574] {aka 6430578P22Rik, C22, Osx}, Egf (epidermal growth factor) [NCBI Gene 13645], ANXA7 (annexin A7) [NCBI Gene 310] {aka ANX7, SNX, SYNEXIN}, Rab11a (RAB11A, member RAS oncogene family) [NCBI Gene 53869], SNX10 (sorting nexin 10) [NCBI Gene 29887] {aka OPTB8}
- **Diseases:** bone loss (MESH:D001847), infection (MESH:D007239), systemic diseases (MESH:D034721), metabolic bone diseases (MESH:D001851), alcohol abuse (MESH:D000437)
- **Chemicals:** DAPI (MESH:C007293), DMSO (MESH:D004121), Alizarin Red S (MESH:C004468), calcium (MESH:D002118), PBS (MESH:D007854), PVDF (MESH:C024865), PFA (MESH:C003043), Th (MESH:D013910), CO2 (MESH:D002245), citrate (MESH:D019343), dexamethasone (MESH:D003907), titanium (MESH:D014025), penicillin (MESH:D010406), A8960 (-), alpha-MEM (MESH:C420642), SDS (MESH:D012967), Baf-A1 (MESH:C040929), ascorbic acid (MESH:D001205), water (MESH:D014867), Triton X-100 (MESH:D017830), streptomycin (MESH:D013307), xylazine (MESH:D014991), ethylenediaminetetraacetic acid (MESH:D004492), paraffin (MESH:D010232), saline (MESH:D012965)
- **Species:** Rodentia (rodent, order) [taxon 9989], Homo sapiens (human, species) [taxon 9606], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), S2a — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12920663/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12920663/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC12920663/full.md

---
Source: https://tomesphere.com/paper/PMC12920663